All data are based on the daily closing price as of January 8, 2025
g

GemVax&KAEL

082270.KQ
11.21 USD
0.53
+4.96%
Created with Highcharts 11.1.0Chart context menu14 Oct21 Oct28 Oct4 Nov11 Nov18 Nov25 Nov2 Dec9 Dec16 Dec23 Dec6 JanJan '23Jan '23Apr '23Apr '23Jul '23Jul '23Oct '23Oct '23Jan '24Jan '24Apr '24Apr '24Jul '24Jul '24Oct '24Oct '24ZoomView 1 month1mView 3 months3mView 6 months6mView year to dateYTDView 1 year1yView allAll8 Oct 20248 Jan 2025

Overview

Last close
11.21 usd
Market cap
399.97M usd
52 week high
16.76 usd
52 week low
7.31 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
9.741
Price/Book Value
8.1782
Enterprise Value
437.59M usd
EV/Revenue
10.1719
EV/EBITDA
-173.0774

Key financials

Revenue TTM
54.10M usd
Gross Profit TTM
12.80M usd
EBITDA TTM
1.58M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
100.46M usd
Net debt
N/A usd

About

GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution prevention; and pressure facility for preventing equipment erosion within a substation; and 5aver, a fire evacuation mask. It also engages in the research and development of anti-cancer immunotherapeutic and peptide drugs; and provides RIAVAX, an immunotherapeutic peptide for the treatment of locally advanced or metastatic pancreatic cancer. The company was founded in 1998 and is headquartered in Daejeon, South Korea.
  • Symbol
    082270.KQ
  • Exchange
    KQ
  • Isin
    KR7082270000
  • Country
    South Korea
  • Sector
    Technology
  • Industry
    Semiconductors & Semiconductor Equipment
  • CEO
    Mr. Sang-Jae Kim
  • Headquarter
    Daejeon
  • Web site
    https://www.gemvax.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top